Diya Nandagopal

@FinMinIndia @nsitharaman @nsitharamanoffc @mppchaudhary @DrBhagwatKarad @PIB_India @DDNewslive @airnewsalerts @cbic_india @IncomeTaxIndia @DFS_India @SecyDIPAM V r anxiously waiting 4 d #Budget2022 n hoping 2 c exemptions on imp duty n GST on #Evrysdi by @Roche as 1st step 2wards affordability 2 life saving drug @cbic_india @GST_Council @Pharmadept @MoHFW_INDIA @PMOIndia @mansukhmandviya. Reqsting Honb'le @nsitharaman Ji 2 consider🙏

A heart wrenching story: Little Diya (11M) born to Bhavana& Nandagopal, was diagnosed with Spinal Muscular Atrophy. Diya’s best hope is Zolgensma, produced by Novartis, costing ₹16 crs - Every bit of help matters. 💙 impactguru.com/fundraiser/hel… #HelpDiya @everyone4diya

This powerful appeal melted my heart: impactguru.com/fundraiser/hel… The lovely baby @everyone4diya deserves a chance at a normal life. If only @Novartis or @NovartisFDN could cut prices for such unfortunate families!

A heart wrenching story: Little Diya (11M) born to Bhavana& Nandagopal, was diagnosed with Spinal Muscular Atrophy. Diya’s best hope is Zolgensma, produced by Novartis, costing ₹16 crs - beyond means of the young couple. Pl pitch in 👉🏿 impactguru.com/fundraiser/hel… #HelpDiya Pl RT 🙏

This happy cherubic baby is 10-month old Diya Nandagopal who is battling Spinal Muscular Atrophy (SMA) type 2, a rare debilitating disease. Her best hope is the gene-therapy cure - Zolgensma, by Novartis which costs Rs.16 Crores. Pls help if you can impactguru.com/fundraiser/hel…